Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling

Doxorubicin-based chemotherapy represents one of the most effective ways in combating human cancers. However, its clinical use is limited by severe side effects. Selenocystine (SeC) is a natural available selenoamino acid with novel anticancer efficacy. In this study, we used SeC to sensitize HepG2...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Cundong, Zheng, Wenjie, Fu, Xiaoyan, Li, Xiaoling, Wong, Yum-Shing, Chen, Tianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058050/
https://www.ncbi.nlm.nih.gov/pubmed/24797310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058050/
https://www.ncbi.nlm.nih.gov/pubmed/24797310

Ejemplares similares